-logo-1200x675.png){kind=logo}
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 20,112 shares, a growth of 228.9% from the June 15th total of 6,115 shares. Based on an average daily trading volume, of 348 shares, the days-to-cover ratio is presently 57.8 days.
CellaVision AB (publ) Price Performance
Shares of CLVSF opened at $14.00 on Monday. The company has a 50 day moving average price of $13.56 and a 200-day moving average price of $15.31. CellaVision AB has a fifty-two week low of $13.49 and a fifty-two week high of $17.30.
About CellaVision AB (publ)
CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.
The company’s core offering revolves around its digital microscopy instruments and proprietary software.
See Also
- Five stocks we like better than CellaVision AB (publ)
- 3 Overlooked Stocks Positioned for the Next Market Rotation
- 3 Non-Tech Stocks Still Winning Big on AI
- Achieve Robust Diversification With These 3 Equal-Weight ETFs
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
